The impact of increased utilization of HIV drugs on longevity and medical expenditure: an assessment based on aggregate US time-series data.
The objective of this Special Report is to estimate the medical cost per life-year gained from increased utilization of HIV drugs by estimating the impact of increased drug utilization on the life expectancy and drug and hospital expenditure of HIV/AIDS patients, using aggregate (US national-level) data for the period 1982-2001.